Influenza Virus H5n1 Subtype
📧 Sign up to get email alerts when something new happens for Influenza Virus H5n1 Subtype.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re... [Phase 1]
This Phase I trial evaluated the safety and immunogenicity of different prime-boost intervals for a monovalent H5N1 influenza vaccine (A/Ind…